查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
鎮咳藥物市場與 COVID-19 影響分析，按藥物類別、按給藥途徑、按年齡層、按最終用戶、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測
市場調查報告書
商品編碼
1339909

鎮咳藥物市場與 COVID-19 影響分析，按藥物類別、按給藥途徑、按年齡層、按最終用戶、按國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

Antitussive Drugs Market with COVID-19 Impact Analysis, By Drug Class, By Route of Administration, By Age Group, By End-Users, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 238 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022年鎮咳藥物市場規模為14.083億美元，2023年至2030年年複合成長率為5.1%。

鎮咳藥市場-市場動態：

  • 咳嗽病例的增加和老年人口的增加將促進市場成長。
  • 推動鎮咳藥物需求的主要因素是咳嗽，這將推動市場成長。此外，呼吸系統疾病的日益流行和大氣污染的嚴重程度增加了個人咳嗽的病例。人們咳嗽和咳嗽的傳染性是世界各地去看基層醫療醫師的最常見目的。因此，持續咳嗽會損害一個人的生活品質；鎮咳藥需求將穩步成長。然而，鎮咳藥物的高成本和發展中國家缺乏醫療基礎設施預計將阻礙市場需求。此外，老年人口更容易患慢性病，預計這將加速市場的成長速度。因此，老年人口的增加預計將推動市場向前發展。

鎮咳藥物市場 - 主要見解：

  • 根據我們的研究分析師分享的分析，預計全球鎮咳藥物市場在預測期內（2023-2030）每年將以 5.1% 左右的年複合成長率成長
  • 由於呼吸道感染、過敏和慢性阻塞性肺病（COPD）等咳嗽相關疾病的廣泛發生，鎮咳藥物行業一直在穩定成長。在流感和寒冷季節，鎮咳藥物的需求往往會激增。
  • 根據藥物類別細分，預計中樞作用藥物將在 2022 年展現出可觀的市場佔有率
  • 一些鎮咳藥物與其他活性成分（例如減充血劑或祛痰劑）結合使用，可以全面緩解多種感冒和流感症狀。

鎮咳藥市場-細分分析：

  • 全球鎮咳藥物市場根據藥物類別、給藥途徑、年齡層、最終用戶和地區進行細分。
  • 市場根據藥物類別分為兩類：外周作用藥物、中樞作用藥物和其他。中樞作用藥物領域可能會在預測期內保持其主導地位。它通過針對咳嗽中樞在大腦中發揮作用，最大限度地減少咳嗽的衝動。此外，這些藥物主要用於治療不產生粘液的持續性乾咳。推動市場的因素包括藥物開發的進步、醫療保健政策的變化、呼吸系統疾病的流行以及消費者對非處方藥或處方藥的偏好。
  • 市場根據給藥途徑分為兩類：吸入、口服和其他。口腔細分市場預計將佔據最高的市場佔有率。它是指對更廣泛的口服鎮咳藥物市場中特定細分市場的市場評估或分析，包括片劑、含片、糖漿和膠囊。
  • 市場根據年齡層分為三類：老年、兒童和成人。預計老年醫學領域將快速成長。老年人口一詞是指 65 歲及以上的個體。該人群具有特殊的醫療保健需求和特徵，這對製藥和醫療保健等多個行業都有影響。
  • 市場根據最終用戶分為三類：家庭護理、醫院、專科診所等。專科診所部門可能擁有最大的市場佔有率。該部門專注於選擇性醫學專業，包括呼吸和肺病學醫學。這些診所通常從事與呼吸系統疾病相關的臨床試驗和研究。此外，這將有助於新鎮咳藥物的測試和開發。

鎮咳藥物市場-地理洞察：

從地域上看，該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

鎮咳藥市場-競爭格局：

這些藥物的易獲得性和認知度的提高將為市場成長提供優勢。此外，隨著公共和私人組織採取主動傳播意識，鎮咳藥物市場將會蓬勃發展。上呼吸道感染病例的增加和可支配收入的增加將導致鎮咳藥物業務的擴張。研發活動數量的增加將提供有利的機會，而藥物上市和批准的增加將進一步推動市場的成長率。例如，2021 年3 月，默克公司宣布，美國食品和藥物管理局(FDA) 已就默克公司的新藥申請(NDA) 發出完整回應函(CRL)，該申請是一種在研口服選擇性P2X3 受體拮抗劑，非-正在開發用於不明原因慢性咳嗽（UCC）或治療成人難治性慢性咳嗽（RCC）的麻醉劑，以討論下一步。

最近的發展：

例如，2021年9月，太陽製藥工業有限公司在印度推出了一種治療咳嗽的新型製劑——Chericof 12（馬來酸氯苯那敏4毫克或氫溴酸右美沙芬30毫克）。

該研究的主要特點：

  • 這項關於鎮咳藥物市場的擬議研究提供了市場規模（百萬美元）、年複合成長率（CAGR%）和預測估計（2023-2030年），以2022年為基準年。
  • 該報告為客戶提供了有關鎮咳藥物市場的最新動態和趨勢見解。
  • 該研究報告闡明了不同細分市場/國家的潛在成長機會，並解釋了鎮咳藥物市場有吸引力的投資主張矩陣。
  • 總體報告確定了新的投資機會、老牌參與者面臨的挑戰以及維持鎮咳藥物市場的成長因素。
  • 研究範圍詳細討論了 COVID-19 對鎮咳藥物市場規模、預測、年複合成長率和市場動態的影響。還將詳細介紹新冠疫情后鎮咳藥物市場的情況。
  • 為了讓本報告的用戶全面了解鎮咳藥物市場，我們還包括了鎮咳藥物市場的競爭格局和關鍵創新者分析。
  • 該研究包括成長前景映射分析，其中所有行業細分都根據其市場規模、成長率和吸引力進行基準測試。
  • 該報告提供了主要市場參與者的詳細公司概況，這些參與者將幫助用戶了解鎮咳藥物市場參與者的財務資訊和戰略舉措。
  • 此外，報告還揭示了全球和區域市場主要參與者的重要收購和兼併、合作和合資、新產品推出、研發、區域擴張。
  • 全球鎮咳藥物市場報告主要面向該行業的各個利益相關者，包括供應商、投資者、新進入者、分銷商和財務分析師。

目錄

第 1 章：鎮咳藥市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按藥物類別分類的鎮咳藥物市場片段
    • 按給藥途徑分類的鎮咳藥物市場片段
    • 按年齡段分類的鎮咳藥物市場片段
    • 最終用戶的鎮咳藥物市場片段
    • 按國家/地區分類的鎮咳藥物市場片段
    • 按地區分類的鎮咳藥市場片段
  • 競爭洞察

第 3 章：鎮咳藥物主要市場趨勢

  • 鎮咳藥市場促進因素
    • 市場促進因素的影響分析
  • 鎮咳藥市場限制
    • 市場限制影響分析
  • 鎮咳藥市場機會
  • 鎮咳藥市場未來趨勢

第 4 章：鎮咳藥行業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：鎮咳藥物市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的細分市場
    • 邊際成長部分
    • 最鬆散的部分
    • 邊際損失部分

第 6 章：鎮咳藥市場格局

  • 2022 年鎮咳藥市場佔有率分析
  • 按主要製造商分類的故障數據
    • 既定玩家分析
    • 新興玩家分析

第 7 章：鎮咳藥物市場 - 按藥物類別

  • 概述
    • 按藥物類別分類的細分市場佔有率分析
    • 外周作用藥物
    • 中樞作用藥物
    • 其他

第 8 章：鎮咳藥物市場 - 按給藥途徑

  • 概述
    • 按給藥途徑分類的細分市場佔有率分析
    • 吸入式
    • 口服
    • 其他

第 9 章：鎮咳藥物市場 - 按年齡層

  • 概述
    • 按年齡層分類的細分市場佔有率分析
    • 老年科
    • 兒科
    • 成人

第 10 章：鎮咳藥物市場 - 按最終用戶

  • 概述
    • 按最終用戶分類的細分市場佔有率分析
    • 家庭護理
    • 醫院
    • 專科診所
    • 其他

第 11 章：鎮咳藥物市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美
    • 概述
    • 北美鎮咳藥物主要製造商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按藥物類別）
    • 北美市場規模和預測（按管理途徑）
    • 北美市場規模和預測（按年齡層）
    • 北美市場規模和預測（按最終用戶）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲鎮咳藥物主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按藥物類別）
    • 歐洲市場規模和預測（按管理途徑）
    • 歐洲市場規模和預測（按年齡段）
    • 歐洲市場規模和預測（按最終用戶）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區鎮咳藥主要製造商
    • 亞太地區市場規模和預測（按國家）
    • 亞太地區市場規模和預測（按藥物類別）
    • 亞太地區市場規模和預測（按管理途徑）
    • 亞太地區市場規模和預測（按年齡層）
    • 亞太地區最終用戶市場規模和預測
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳大利亞
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲鎮咳藥物主要製造商
    • 拉丁美洲市場規模和預測（按國家）
    • 拉丁美洲市場規模和預測（按藥物類別）
    • 拉丁美洲市場規模和預測（按管理途徑）
    • 拉丁美洲市場規模和預測（按年齡層）
    • 拉丁美洲市場規模和預測（按最終用戶）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲鎮咳藥主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按藥物類別）
    • 中東和非洲市場規模及預測（按管理途徑）
    • 中東和非洲市場規模及預測（按年齡層）
    • 中東和非洲市場規模和預測（按最終用戶）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 火雞
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 12 章：主要供應商分析-止咳藥行業

  • 競爭儀表板
  • 公司簡介
    • Teva Pharmaceutical Industries Ltd.
    • Intas Pharmaceuticals Ltd.
    • Bayer AG
    • Aceto
    • Sanofi
    • Ipca Laboratories Ltd.
    • 3M
    • F. Hoffmann-La Roche Ltd.
    • Hikma Pharmaceuticals PLC
    • Unique Pharmaceuticals Limited
    • Cipla Inc.
    • Mylan NV
    • Zydus Cadila
    • Sanofi
    • Novartis AG
    • Aurobindo Pharma

第 13 章：360 度分析師視角

第 14 章：附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯繫我們
Product Code: ANV1633

REPORT HIGHLIGHT

Antitussive drugs market size was valued at USD 1,408.3 Million in 2022, expanding at a CAGR of 5.1% from 2023 to 2030.

Antitussive drugs are defined as heterogeneous medications commonly used in patients suffering from respiratory disorders to suppress dry cough. In addition, various symptoms caused by common allergies, colds, flu, hay fever, or other breathing disorders like bronchitis and sinusitis can be treated by antitussive drugs. These drugs act on the cough center in the brain to reduce the urge to cough in patients. They are either opioids or opiates such as dextromethorphan, pholcodine, and codeine. Moreover, one of the commonly used drugs is dextromethorphan over-the-counter antitussive drugs, and it is relatively safe.

Antitussive Drugs Market- Market Dynamics:

  • Rising cough cases and the geriatric population will augment the market growth.
  • The major element boosting demand for antitussive drugs is cough, which will drive the market growth. In addition, the growing prevalence of respiratory disorders and the high rate of atmospheric pollution increase the cases of cough in individuals. The contagious nature of people's coughs and coughs is the most common purpose to visit primary care physicians across the world. Thus, persistent cough can harm a person's quality of life; the demand for antitussive drugs will witness steady growth. However, the high cost of antitussive drugs and the lack of healthcare infrastructure in developing nations are expected to hamper the market demand. Furthermore, the older population is more prone to chronic disease, which is anticipated to accelerate the market's growth rate. Thus, the rise in the geriatric population will be projected to drive the market forward.

Antitussive Drugs Market- Key Insights:

  • As per the analysis shared by our research analyst, the global antitussive drugs market is estimated to grow annually at a CAGR of around 5.1% over the forecast period (2023-2030)
  • The antitussive drugs industry has been witnessing steady growth due to the widespread occurrence of cough-related conditions, including respiratory infections, allergies, and chronic obstructive pulmonary disease (COPD). The demand for antitussive medications tends to spike during flu and cold seasons.
  • Based on drug class form segmentation, Centrally Acting Drugs was predicted to show promising market share in the year 2022
  • Some antitussive medications are combined with other active ingredients, such as decongestants or expectorants, to provide comprehensive relief from multiple cold and flu symptoms.

Antitussive Drugs Market- Segmentation Analysis:

  • The Global antitussive drugs market is segmented on the basis of drug class, route of administration, age group, end-users, and region.
  • The market is divided into two categories based on drug class: peripherally acting drugs, centrally acting drugs, and others. The centrally acting drugs segment is likely to maintain its dominance over the forecast period. It works in the brain by targeting the cough center, minimizing the urge to cough. Additionally, these medications are mostly preferred to treat persistent dry coughs that don't produce mucus. The factors propelling the market include advances in drug development, changes in healthcare policies, the prevalence of respiratory conditions, and consumer preferences for over-the-counter or prescription medications.
  • The market is divided into two categories based on the route of administration: inhalational, oral, and others. The oral segment is expected to hold the highest market share. It refers to a market assessment or analysis of a particular segment within the broader antitussive drugs market which are administered orally including tablets, lozenges, syrups, and capsules.
  • The market is divided into three categories based on age group: geriatric, pediatric, and adult. The geriatric segment is anticipated to witness speedy growth. The term geriatric population refers to individuals 65 and older. This population has special healthcare needs and traits that have implications for several industries, such as pharmaceuticals and healthcare.
  • The market is divided into three categories based on end-users: homecare, hospitals, specialty clinics, and others. The specialty clinics segment is likely to possess the largest market share. The segment focuses on selective medical specialties, including respiratory and pulmonology medicine. The clinics commonly engaged in clinical trials and research related to respiratory diseases. Additionally, this will assist in the testing and development of new antitussive drugs.

Antitussive Drugs Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Antitussive Drugs Market- Competitive Landscape:

Easy availability and rising awareness of these drugs will offer advantages for market growth. Moreover, the antitussive drugs market will boost as public and private organizations take initiatives to spread awareness. Rising infection cases of the upper respiratory tract and high disposable income will result in the expansion of the antitussive drugs business. An increase in the number of research and development activities will provide beneficial opportunities as well as rising drug launches and approvals will further propel the market's growth rate. For instance, in March 2021, Merck announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding Merck's New Drug Application (NDA) for gefapixant, the investigational, orally administered selective P2X3 receptor antagonist, non-narcotic under development for the unexplained chronic cough (UCC) or treatment of refractory chronic cough (RCC) in adults agency to discuss the next steps.

Recent Developments:

For instance, in September 2021, Sun Pharmaceutical Industries Ltd. launched of a novel formulation in cough management - Chericof 12 (chlorpheniramine maleate 4 mg or dextromethorphan hydrobromide 30 mg) in India.

Key features of the study:

  • This proposed research study on antitussive drugs market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year.
  • The report provides the client the latest up-to-date and trending insights about the antitussive drugs market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for antitussive drugs market.
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the antitussive drugs market.
  • Impact of COVID-19 on antitussive drugs market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on antitussive drugs market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the antitussive drugs market, we have also included competitive landscape and key innovator analysis for the antitussive drugs market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants who will help users to understand their financial information and strategic initiatives of players operating in the antitussive drugs market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global antitussive drugs market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ANTITUSSIVE DRUGS MARKET KEY PLAYERS

  • Teva Pharmaceutical Industries Ltd.
  • Intas Pharmaceuticals Ltd.
  • Bayer AG
  • Aceto
  • Sanofi
  • Ipca Laboratories Ltd.
  • 3M
  • F. Hoffmann-La Roche Ltd.
  • Hikma Pharmaceuticals PLC
  • Unique Pharmaceuticals Limited
  • Cipla Inc.
  • Mylan N.V.
  • Zydus Cadila
  • Sanofi
  • Novartis AG
  • Aurobindo Pharma

GLOBAL ANTITUSSIVE DRUGS MARKET, BY DRUG CLASS

  • Peripherally Acting Drugs
  • Centrally Acting Drugs
  • Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY ROUTE OF ADMINISTRATION

  • Inhalational
  • Oral
  • Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY AGE GROUP

  • Geriatric
  • Pediatric
  • Adult

GLOBAL ANTITUSSIVE DRUGS MARKET, BY END-USERS

  • Homecare
  • Hospitals
  • Specialty Clinics
  • Others

GLOBAL ANTITUSSIVE DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Antitussive Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Antitussive Drugs Market Snippet by Drug Class
    • 2.1.2. Antitussive Drugs Market Snippet by Route of Administration
    • 2.1.3. Antitussive Drugs Market Snippet by Age Group
    • 2.1.4. Antitussive Drugs Market Snippet by End-Users
    • 2.1.5. Antitussive Drugs Market Snippet by Country
    • 2.1.6. Antitussive Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Antitussive Drugs Key Market Trends

  • 3.1. Antitussive Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Antitussive Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Antitussive Drugs Market Opportunities
  • 3.4. Antitussive Drugs Market Future Trends

4. Antitussive Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Antitussive Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Antitussive Drugs Market Landscape

  • 6.1. Antitussive Drugs Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Antitussive Drugs Market - By Drug Class

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Drug Class, 2022&2030 (%)
    • 7.1.2. Peripherally Acting Drugs
    • 7.1.3. Centrally Acting Drugs
    • 7.1.4. Others

8. Antitussive Drugs Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2022&2030 (%)
    • 8.1.2. Inhalational
    • 8.1.3. Oral
    • 8.1.4. Others

9. Antitussive Drugs Market - By Age Group

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Age Group, 2022&2030 (%)
    • 9.1.2. Geriatric
    • 9.1.3. Pediatric
    • 9.1.4. Adult

10. Antitussive Drugs Market - By End-Users

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By End-Users, 2022&2030 (%)
    • 10.1.2. Homecare
    • 10.1.3. Hospitals
    • 10.1.4. Specialty Clinics
    • 10.1.5. Others

11. Antitussive Drugs Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2022&2030 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Antitussive Drugs Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Antitussive Drugs Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.9. Italy
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.9.3. Italy Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.9.4. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.9.5. Italy Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.9.6. Italy Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.10. United Kingdom
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.10.3. United Kingdom Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.10.4. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.10.5. United Kingdom Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.10.6. United Kingdom Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.11. France
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.11.3. France Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.11.4. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.11.5. France Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.11.6. France Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.12. Russia
      • 11.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.12.2. Russia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.12.3. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.12.4. Russia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.12.5. Russia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.13. Netherlands
      • 11.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.13.2. Netherlands Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.13.3. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.13.4. Netherlands Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.13.5. Netherlands Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.14.2. Sweden Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.15. Poland
      • 11.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.15.2. Poland Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.15.3. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.15.4. Poland Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.15.5. Poland Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.3.16. Rest of Europe
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.3.16.3. Rest of the Europe Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.3.16.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.3.16.5. Rest of the Europe Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.3.16.6. Rest of the Europe Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Antitussive Drugs Key Manufacturers in Asia Pacific
    • 11.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.4.4. Asia Pacific Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.4.5. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.4.7. Asia Pacific Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.8. India
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.8.3. India Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.8.4. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.8.5. India Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.8.6. India Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.9. China
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.9.3. China Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.9.4. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.9.5. China Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.9.6. China Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.13. Thailand
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.13.3. Thailand Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.13.4. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.13.5. Thailand Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.13.6. Thailand Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.14. Indonesia
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.14.3. Indonesia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.14.4. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.14.5. Indonesia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.14.6. Indonesia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.5. Latin America
    • 11.5.1. Overview
    • 11.5.2. Antitussive Drugs Key Manufacturers in Latin America
    • 11.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.5.4. Latin America Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.5.5. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.5.6. Latin America Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.5.7. Latin America Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
  • 11.6. Middle East and Africa
    • 11.6.1. Overview
    • 11.6.2. Antitussive Drugs Key Manufacturers in Middle East and Africa
    • 11.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 11.6.4. Middle East and Africa Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
    • 11.6.5. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 11.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
    • 11.6.7. Middle East and Africa Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Drug Class, 2018 - 2030 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Age Group, 2018 - 2030 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End-Users, 2018 - 2030 (US$ Million)

12. Key Vendor Analysis- Antitussive Drugs Industry

  • 12.1. Competitive Dashboard
  • 12.2. Company Profiles
    • 12.2.1. Teva Pharmaceutical Industries Ltd.
    • 12.2.2. Intas Pharmaceuticals Ltd.
    • 12.2.3. Bayer AG
    • 12.2.4. Aceto
    • 12.2.5. Sanofi
    • 12.2.6. Ipca Laboratories Ltd.
    • 12.2.7. 3M
    • 12.2.8. F. Hoffmann-La Roche Ltd.
    • 12.2.9. Hikma Pharmaceuticals PLC
    • 12.2.10. Unique Pharmaceuticals Limited
    • 12.2.11. Cipla Inc.
    • 12.2.12. Mylan N.V.
    • 12.2.13. Zydus Cadila
    • 12.2.14. Sanofi
    • 12.2.15. Novartis AG
    • 12.2.16. Aurobindo Pharma

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Antitussive Drugs Market: Drug Class Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Drug Class
  • TABLE Global Antitussive Drugs Market, by Drug Class2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: Route of AdministrationSnapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Antitussive Drugs Market, by Route of Administration2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: Age Group Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Age Group
  • TABLE Global Antitussive Drugs Market, by Age Group 2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: End-Users Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End-Users
  • TABLE Global Antitussive Drugs Market, by End-Users 2018-2030 (USD Million)
  • TABLE Antitussive Drugs Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Antitussive Drugs Market, by Region 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE North America Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Europe Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Asia Pacific Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Latin America Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Drug Class, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by Age Group, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Antitussive Drugs Market, by End-Users, 2018-2030 (USD Million)

List of Figures

  • FIGURE Antitussive Drugs Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Drug Class segment market share analysis, 2022&2030
  • FIGURE Drug Class segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022&2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Age Group segment market share analysis, 2022&2030
  • FIGURE Age Groupsegment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE End-Users segment market share analysis, 2022&2030
  • FIGURE End-Users segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022&2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Antitussive Drugs Market share and leading players, 2022
  • FIGURE Europe Antitussive Drugs Market share and leading players, 2022
  • FIGURE Asia Pacific Antitussive Drugs Market share and leading players, 2022
  • FIGURE Latin America Antitussive Drugs Market share and leading players, 2022
  • FIGURE Middle East and Africa Antitussive Drugs Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Antitussive Drugs Market share analysis by country, 2022
  • FIGURE Germany Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Antitussive Drugs Market share analysis by country, 2022
  • FIGURE India Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Antitussive Drugs Market share analysis by country, 2022
  • FIGURE Brazil Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Antitussive Drugs Market share analysis by country, 2022
  • FIGURE Saudi Arabia Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Antitussive Drugs Market size, forecast and trend analysis, 2018 to 2030 (USD Million)